1st March 2025, Kathmandu
TIME Pharmaceuticals Limited plans to issue shares to the public through the Book Building method. This initiative aligns with the guidelines in the Securities Registration and Issuance Regulations.
TIME Pharmaceuticals IPO Nepal
The company has secured the required approvals from relevant regulatory bodies. With these approvals in place, the public offering will proceed as planned.
Nabil Investment Banking Appointed as Manager
To manage the share issuance, TIME Pharmaceuticals has appointed Shree Nabil Investment Banking Limited as the Share Issuance and Sales Manager. Nabil will oversee the process, ensuring the smooth execution of the public offering.
A Legacy of Excellence
For over 30 years, TIME Pharmaceuticals has been a leader in the pharmaceutical industry in Nepal. Its headquarters is located in Gaindakot, Nawalparasi District, within Gandaki Province. The company also operates a production facility in Gaindakot, Ward No. 10, and a marketing office in Lalitpur.
With a workforce of over 300 employees, TIME Pharmaceuticals has established itself as a WHO-GMP Certified organization known for its dedication to quality. The company produces over 200 different medicines across various therapeutic segments.
Popular Brands and Products
TIME Pharmaceuticals offers well-known brands such as Sinex, Paraflam, Salif, Pulmarin, AZT, SITA-M, Clarith, Folvin, T-Zoline, and Himox. These products serve the healthcare needs of people across Nepal.
The company has become synonymous with high-quality medicines, contributing to self-sufficiency in the country’s healthcare sector. Its commitment to providing essential medicines has played a vital role in meeting the health needs of the nation.
Expanding Network and Future Plans
In addition to domestic operations, TIME Pharmaceuticals has formed strategic partnerships with international companies. It collaborates with SQUARE Pharmaceuticals Plc. in Bangladesh and HK-VJM Limited in Hong Kong to expand its market reach. This collaboration allows the company to export its products to other countries, and there are plans to further extend its export market in the future.
Share Issuance Agreement Signed
On 15th Falgun 2081 (March 1, 2025), TIME Pharmaceuticals signed an agreement to appoint Shree Nabil Investment Banking Limited as the Share Issuance and Sales Manager. The agreement was signed by Mr. Surdashan Lal Shrestha, Managing Director of TIME Pharmaceuticals, and Mr. Manish Narayan Joshi, CEO of Nabil Investment Banking.
This public share issuance marks a major milestone for TIME Pharmaceuticals as it seeks to expand its operations and continue contributing to Nepal’s healthcare industry.
For more: TIME Pharmaceuticals IPO Nepal